We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Daiichi Sankyo Co Ltd | TG:D4S | Tradegate | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| -0.06 | -0.22% | 26.82 | 26.62 | 27.02 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 27.11 | 26.63 | 26.63 | 230 | 22:50:10 |
| Date | Time | Source | Headline |
|---|---|---|---|
| 24/12/2024 | 08:20 | ALNC |  AstraZeneca and Daiichi withdraw EU application for lung cancer drug |
| 09/12/2024 | 09:09 | ALNC | AstraZeneca, Daiichi Sankyo hail US breakthrough therapy designation |
| 19/11/2024 | 15:47 | ALNC | AstraZeneca "disappointed" as breast cancer drug blocked for NHS use |
| 14/10/2024 | 09:42 | ALNC | TOP NEWS: Enhertu by AstraZeneca, Daiichi wins new approval in China |
| 01/10/2024 | 08:39 | ALNC | TOP NEWS: AstraZeneca and Daiichi hail Enhertu priority review in US |
| 23/9/2024 | 07:44 | ALNC | TOP NEWS: AstraZeneca cancer drug fails to significantly extend lives |
| 17/9/2024 | 19:15 | ALNC | IN BRIEF: Merck and Daiichi Sankyo's patritumab effective in phase 3 |
| 13/9/2024 | 16:00 | ALNC | Daiichi, Astra's Enhertu shows clinical activity in brain metastases |
| 19/8/2024 | 08:31 | ALNC | AstraZeneca and Daiichi Sankyo gets US and European nods for Enhertu |
| 13/8/2024 | 10:38 | ALNC | AstraZeneca and Daiichi Sankyo get new approval in China for Enhertu |
1 Year Daiichi Sankyo Chart |
Intraday Daiichi Sankyo Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
